PL297870A1 - Substituted sulfonylbenzylopyridones as well as method of obtaining and drugs containing them - Google Patents

Substituted sulfonylbenzylopyridones as well as method of obtaining and drugs containing them

Info

Publication number
PL297870A1
PL297870A1 PL29787093A PL29787093A PL297870A1 PL 297870 A1 PL297870 A1 PL 297870A1 PL 29787093 A PL29787093 A PL 29787093A PL 29787093 A PL29787093 A PL 29787093A PL 297870 A1 PL297870 A1 PL 297870A1
Authority
PL
Poland
Prior art keywords
sulfonylbenzylopyridones
substituted
obtaining
well
drugs containing
Prior art date
Application number
PL29787093A
Other languages
English (en)
Inventor
Rudolf Hanko
Walter Huebsch
Juergen Dressel
Peter Fey
Thomas Kraemer
Ulrich E Mueller
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Claudia Hirth-Dietrich
Andreas Knorr
Johannes-Peter Stasch
Stefan Wohlfeil
Oezkan Yalkinoglu
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL297870A1 publication Critical patent/PL297870A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PL29787093A 1992-02-27 1993-02-25 Substituted sulfonylbenzylopyridones as well as method of obtaining and drugs containing them PL297870A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4206045A DE4206045A1 (de) 1992-02-27 1992-02-27 Sulfonylbenzyl substituierte pyridone

Publications (1)

Publication Number Publication Date
PL297870A1 true PL297870A1 (en) 1993-10-04

Family

ID=6452730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL29787093A PL297870A1 (en) 1992-02-27 1993-02-25 Substituted sulfonylbenzylopyridones as well as method of obtaining and drugs containing them

Country Status (18)

Country Link
US (1) US5254543A (cg-RX-API-DMAC7.html)
EP (1) EP0557843A3 (cg-RX-API-DMAC7.html)
JP (1) JPH0641081A (cg-RX-API-DMAC7.html)
KR (1) KR930017898A (cg-RX-API-DMAC7.html)
CN (1) CN1078468A (cg-RX-API-DMAC7.html)
AU (1) AU653288B2 (cg-RX-API-DMAC7.html)
CA (1) CA2090267A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ15793A3 (cg-RX-API-DMAC7.html)
DE (1) DE4206045A1 (cg-RX-API-DMAC7.html)
HU (1) HUT64057A (cg-RX-API-DMAC7.html)
IL (1) IL104843A0 (cg-RX-API-DMAC7.html)
MX (1) MX9300766A (cg-RX-API-DMAC7.html)
MY (1) MY129973A (cg-RX-API-DMAC7.html)
NZ (1) NZ245999A (cg-RX-API-DMAC7.html)
PL (1) PL297870A1 (cg-RX-API-DMAC7.html)
SK (1) SK14593A3 (cg-RX-API-DMAC7.html)
TW (1) TW230206B (cg-RX-API-DMAC7.html)
ZA (1) ZA931370B (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4215587A1 (de) * 1992-05-12 1993-11-18 Bayer Ag Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
JPH06306073A (ja) * 1992-12-10 1994-11-01 Japan Tobacco Inc ニコチン誘導体の光学分割法
WO2000058304A1 (en) * 1999-03-26 2000-10-05 Shionogi & Co., Ltd. Heterocyclic sulfonamide derivatives
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
CA2469435A1 (en) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AP1822A (en) * 2002-02-14 2008-01-30 Pharmacia Corp Substituted pyridinones as modulators of P38 MAP kinase.
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
BRPI0608469A2 (pt) 2005-04-22 2010-01-05 Alantos Pharmaceuticals Holding Inc inibidores de dipeptidil peptidase-iv
GB0514686D0 (en) * 2005-07-18 2005-08-24 Novartis Ag Organic compounds
CN1985878B (zh) * 2005-12-20 2011-06-22 广州王老吉药业股份有限公司 一种治疗消化性溃疡的药物组合物及其制备方法
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
WO2009033703A1 (en) * 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
ATE516272T1 (de) 2007-09-14 2011-07-15 Ortho Mcneil Janssen Pharm 1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
RS51660B (sr) 2007-09-14 2011-10-31 Ortho-Mcneil-Janssen Pharmaceuticals Inc. 1`,3`-disupstituisani-4-fenil-3,4,5,6-tetrahidro-2h, 1`h-[1,4`] bipiridinil-2`-oni
EP2220083B1 (en) * 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
AU2009331659B2 (en) 2008-12-23 2015-09-03 F. Hoffmann-La Roche Ag Dihydropyridone amides as P2X7 modulators
CN102264701A (zh) 2008-12-23 2011-11-30 霍夫曼-拉罗奇有限公司 作为p2x7调节剂的二氢吡啶酮脲
CA2745952A1 (en) 2008-12-23 2010-07-01 F.Hoffmann-La Roche Ag Dihydropyridone amides as p2x7 modulators
WO2010072605A1 (en) 2008-12-23 2010-07-01 F. Hoffmann-La Roche Ag Dihydropyridone amides as p2x7 modulators
US8153808B2 (en) 2008-12-23 2012-04-10 Roche Palo Alto Llc Dihydropyridone amides as P2X7 modulators
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
KR20120035158A (ko) 2009-05-12 2012-04-13 얀센 파마슈티칼즈, 인코포레이티드 1,２,４?트리아졸로［４,３?ａ］피리딘 유도체 및 ｍＧｌｕＲ２ 수용체의 양성 알로스테릭 조절자로서의 그의 용도
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CA2814996C (en) 2010-11-08 2019-10-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
CN109999033B (zh) 2014-01-21 2022-12-23 詹森药业有限公司 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
HRP20191646T1 (hr) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
SG52330A1 (en) * 1989-06-14 1998-09-28 Smithkline Beecham Corp Imidazolyl-alkenoic acids
FI916130A7 (fi) * 1989-06-30 1991-12-27 Du Pont Aryylisubstituoituja imidatsoleja
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
NZ238624A (en) * 1990-06-19 1994-08-26 Meiji Seika Co Pyridine derivatives, compositions, preparations and use thereof

Also Published As

Publication number Publication date
IL104843A0 (en) 1993-06-10
HUT64057A (en) 1993-11-29
JPH0641081A (ja) 1994-02-15
CZ15793A3 (en) 1993-12-15
AU3377093A (en) 1993-09-02
CA2090267A1 (en) 1993-08-28
CN1078468A (zh) 1993-11-17
EP0557843A3 (en) 1993-12-01
TW230206B (cg-RX-API-DMAC7.html) 1994-09-11
AU653288B2 (en) 1994-09-22
ZA931370B (en) 1993-03-23
KR930017898A (ko) 1993-09-20
HU9300545D0 (en) 1993-05-28
MX9300766A (es) 1993-08-01
MY129973A (en) 2007-05-31
EP0557843A2 (de) 1993-09-01
NZ245999A (en) 1995-10-26
DE4206045A1 (de) 1993-09-02
US5254543A (en) 1993-10-19
SK14593A3 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
PL297870A1 (en) Substituted sulfonylbenzylopyridones as well as method of obtaining and drugs containing them
PL300335A1 (en) Pharmaceutical agent, novel derivatives of 4-thiazinylinone and method of obtaining such novel derivatives
PL297904A1 (en) Method of obtaining bisephenol
HUT64774A (en) Method for producing peptones inhibiting activity of hiv-protease and one for prdeparing such medical preparatives
PL315174A1 (en) Novel derivatives of gingolydes and method of obtaining them
PL297716A1 (en) Benzimidazolyl derivatives, method of obtaining them and therapeutic agents containing such compounds
IL103772A0 (en) Bloodbag and method of making same
PL308361A1 (en) Novel taxane derivatives, method of obtaining them and pharmaceutical agents containing such derivatives
GB2268185B (en) Oily preparation and method of production thereof
PL299369A1 (en) Novel epoxy compounds, method of obtainining them and pharmaceutical preparation containing them
PL287591A1 (en) Pesticide and method of its synthesis
PL301204A1 (en) Method of obtaining avermectines and invermectines
PL301355A1 (en) Sybstituted hydroxy cimmamides, method of obtaining them and agents containing such compounds and their application
PL302373A1 (en) Derivatives of substituted imidazobenzoxazin-1-one and method of obtaining them
PL300822A1 (en) Method of obtaining polyoxyphenylenes and polyoxyphenylenes obtained thereby
PL307050A1 (en) Therapeutic system and method of obtaining same
PL303822A1 (en) Therapeutic compositions containing ipsapyrone and method of obtaining them
PL297872A1 (en) Substituted sulfonylbenzyloimidazopyridines, method of obtaining them and drugs containing them
PL302250A1 (en) Purified form of streptogramines, method of obtaining same and pharmaceutical agents containing it
PL301188A1 (en) Novel heterocyclic compounds, therapeutic agents containing them and method of obtaining such compounds
HU9203899D0 (en) Method for producing spiro-oxindole derivatives and pharmaceutical preparatives containing them
PL299768A1 (en) Derivative of 21-chloropregnane, method of obtaining such derivative, pharmaceutical preparation containing it and application of such derivative
PL299689A1 (en) Novel thiadiazinone derivatives and method of obtaining sames
HU9301041D0 (en) Method for producing new tri-substituted cycloalcane derivatives and medical preparatives containing them
PL301246A1 (en) Novel derivatives of pradimycine, method of obtaining them and pharmaceutical agent containing such derivatives